| Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues CM Bailey, Y Liu, M Liu, X Du, M Devenport, P Zheng, Y Liu, Y Wang The Journal of Clinical Investigation 132 (9), 2022 | 55 | 2022 |
| Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer CM Bailey, Y Liu, G Peng, H Zhang, M He, D Sun, P Zheng, Y Liu, Y Wang Nanomedicine: Nanotechnology, Biology and Medicine 29, 102278, 2020 | 53 | 2020 |
| The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin G Peng, Y Wang, P Ge, C Bailey, P Zhang, D Zhang, Z Meng, C Qi, ... Journal of Experimental & Clinical Cancer Research 40, 1-16, 2021 | 38 | 2021 |
| Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin Y Wang, Y Liu, C Bailey, H Zhang, M He, D Sun, P Zhang, B Parkin, ... Oncogene 39 (14), 3015-3027, 2020 | 29 | 2020 |
| Effects of recombinant methionyl bovine somatotropin (sometribove) in high producing cows milked three times daily DC Jordan, AA Aguilar, JD Olson, C Bailey, GF Hartnell, KS Madsen Journal of dairy science 74 (1), 220-226, 1991 | 29 | 1991 |
| PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation M Scarpa, P Singh, CM Bailey, JK Lee, S Kapoor, RG Lapidus, ... Molecular cancer therapeutics 20 (4), 676-690, 2021 | 19 | 2021 |
| Dual targeting oncoproteins MYC and HIF1α regresses tumor growth of lung cancer and lymphoma X Huang, Y Liu, Y Wang, C Bailey, P Zheng, Y Liu Cancers 13 (4), 694, 2021 | 15 | 2021 |
| Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor Y Liu, MV Nelson, C Bailey, P Zhang, P Zheng, JS Dome, Y Liu, Y Wang Oncogene 40 (29), 4809-4819, 2021 | 14 | 2021 |
| A short-term study evaluating the galactopoietic effects of the administration of Sometribove (recombinant methionyl bovine somatotropin) in high producing dairy cows milked … AA Aguilar, DC Jordan, JD Olson, C Bailey, GF Hartnell | 12 | 1988 |
| A novel aptamer-based small RNA delivery platform and its application to cancer therapy T Tanno, P Zhang, C Bailey, Y Wang, W Ittiprasert, M Devenport, P Zheng, ... Genes & Diseases 10 (3), 1075-1089, 2023 | 3 | 2023 |
| Correction: targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor Y Liu, MV Nelson, C Bailey, P Zhang, P Zheng, JS Dome, Y Liu, Y Wang Oncogene 41 (9), 1383-1383, 2022 | 2 | 2022 |
| Echinomycin formulation, method of making and method of use thereof Y Liu, Y Wang, Y Liu, C Bailey, P Zheng US Patent 11,116,726, 2021 | 2 | 2021 |
| Treatment of graft-versus-host disease by echinomycin in a new humanized mouse model Y Liu, C Bailey, C Lazarski, C Wong, P Zheng, Y Liu, Y Wang bioRxiv, 108951, 2017 | 2 | 2017 |
| Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease C Bailey, Y Wei, J Yan, D Huang, P Zhang, C Qi, C Lazarski, JJ Su, ... Cell Reports Medicine 4 (11), 2023 | 1 | 2023 |
| Highly-Accumulated HIF-1A is a Potential Therapeutic Target in the Treatment of Wilms Tumor M Nelson, Y Liu, C Bailey, Y Liu, J Dome, Y Wang PEDIATRIC BLOOD & CANCER 64, S7-S7, 2017 | 1 | 2017 |
| PCR197 Right Member, Right Time, Right Care: Evaluating Blue Cross and Blue Shield of Louisiana’s Impactability Score R Zhang, Y Zhang, E Lucas, M Liu, C Bailey, T Bergeron, K Nikolaus, ... Value in Health 26 (6), S348, 2023 | | 2023 |
| HSD43 Impactability Score: A New Tool in the Management of High-Risk Members R Zhang, Y Zhang, M Liu, C Bailey, T Bergeron, K Nikolaus, D Barfield, ... Value in Health 25 (7), S487, 2022 | | 2022 |
| MEASURING IMPACTABILITY: A GAME CHANGER IN THE MANAGEMENT OF HIGH RISK MEMBERS A-A BLUE CROSS BLUE SHIELD OF LOUISIANA PILOT Y Zhang, R Zhang, M Liu, T Diller, K Nikolaus, J Chaisson, C Bailey, ... VALUE IN HEALTH 24, S151-S151, 2021 | | 2021 |
| PMU40 Measuring Impactability: A Game Changer in the Management of High Risk Members –A Blue Cross Blue Shield of Louisiana Pilot Y Zhang, R Zhang, M Liu, T Diller, K Nikolaus, J Chaisson, C Bailey, ... Value in Health 24, S151, 2021 | | 2021 |
| Genetic and Pharmaceutical Targeting of HIF-1α Enhances PD-L1 Expression in Normal Tissue while Repressing It in Cancer: An Optimal Strategy for Combination Immunotherapy CM Bailey The George Washington University, 2021 | | 2021 |
